Reduced expression and increased CpG dinucleotide methylation of the rat APOBEC-1 promoter in transgenic rabbits

Biochimica et Biophysica Acta - Gene Structure and Expression

Volumn 1577, Issue 3, 2002, Pages 384-394

  Apostel, Frank ^a   Dammann, Reinhard ^b   Pfeifer, Gerd P ^c   Greeve, Jobst ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Apolipoprotein B; CpG dinucleotide methylation; mRNA editing; Promoter; Transgenic rabbit

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 1; CYTIDINE DEAMINASE; DINUCLEOTIDE; UNCLASSIFIED DRUG;

ARTICLE; BLOOD LEVEL; CATALYSIS; CATALYST; CONTROLLED STUDY; CPG ISLAND; DEMETHYLATION; DOWN REGULATION; HORSE; METHYLATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RAT; REDUCTION; TISSUE DISTRIBUTION; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; BASE SEQUENCE; CPG ISLANDS; CYTIDINE DEAMINASE; INTESTINES; KIDNEY; LIVER; METHYLATION; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); RABBITS; RATS; SPECIES SPECIFICITY;

CANIS FAMILIARIS; EQUIDAE; ORYCTOLAGUS CUNICULUS;

EID: 0037184265     PISSN: 01674781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4781(02)00412-8     Document Type: Article

References (32)

1. Powell L.M., Wallis S.C., Pease R.J., Edwards Y.H., Knott T.J., Scott J. A novel form of tissue-specific RNA processing produces apo B-48 in the intestine. Cell. 50:1987;831-840.
2. Chen S.H., Habib G., Yang C.Y., Gu Z.W., Lee B.R., Weng S.A., Silbermann S.R., Cai S.J., Deslypere J.P., Rosseneu M., Gotto A.M., Li W.H., Chan L. Apo B-48 is the product from a messenger RNA with an organ-specific in-frame translational stop codon. Science. 238:1987;363-366.
3. Goldstein J.L., Brown M.S. A receptor-mediated pathway for cholesterol-homeostasis. Science. 232:1986;34-47.
4. Innerarity T.L., Boren J., Yamanaka S., Olofson S.-O. Biosynthesis of apolipoprotein B-48 containing lipoproteins. J. Biol. Chem. 271:1996;2353-2356.
5. Greeve J., Altkemper I., Dieterich J.H., Greten H., Windler E. Apolipoprotein B mRNA editing in 12 different mammalian species: hepatic expression is reflected in low concentrations of apo B-containing plasma lipoproteins. J. Lipid Res. 34:1993;1367-1382.
6. Teng B.B., Burand C.F., Davidson N.O. Molecular cloning of an apolipoprotein B messenger RNA editing protein. Science. 260:1993;1816-1819.
7. Mehta A., Kinter M.L., Sherman N.E., Driscoll D.M. Molecular cloning of Apobec-1 complementation factor, a novel RNA binding protein involved in the editing of apolipoprotein B mRNA. Mol. Cell. Biol. 20:2000;1846-1854.
8. Lellek H., Kirsten R., Diehl I., Apostel F., Buck F., Greeve J. Purification and molecular cloning of a novel essential component of the apolipoprotein B mRNA editing enzyme-complex. J. Biol. Chem. 275:2000;19848-19856.
9. Navaratnam N., Bhattacharya S., Fufino T., Patel D., Jaumuz A.L., Scott J. Evolutionary origins of apo B mRNA editing: catalysis by a cytidine deaminase that has acquired a novel RNA-binding motif at its active site. Cell. 81:1995;187-195.
10. Yamanaka S., Poksay K.S., Balestra M.E., Zeng G.Q., Innerarity T.L. Cloning and mutagenesis of the rabbit apo B mRNA editing protein. J. Biol. Chem. 269:1994;21725-21734.
11. Nakamuta M., Oka K., Krushkal J., Kobayashi K., Yamamoto M., Li W.H., Chan L. Alternative mRNA splicing and differential promoter utilization determine tissue-specific expression of the apolipoprotein B mRNA editing protein (APOBEC-1) gene in mice. J. Biol. Chem. 270:1995;13042-13056.
12. Qian X., Balestra M.E., Innerarity T.L. Two distinct TATA-less promoters direct tissue-specific expression of the rat apo B editing catalytic polypeptide 1 gene. J. Biol. Chem. 272:1997;18060-18070.
13. Hirano K.I., Min J., Funahashi T., Davidson N.O. Cloning and characterization of the rat APOBEC-1 gene: a comparative analysis of gene structure and promoter usage in rat and mouse. J. Lipid Res. 38:1997;1103-1118.
14. Greeve J., Axelos D., Welker S., Schipper M., Greten H. Distinct promoters induce APOBEC-1 expression in rat liver and intestine. Arterioscler. Thromb. Vasc. Biol. 18:1998;1079-1092.
15. Greeve J., Jona V.K., Chowdhury N.R., Horwitz M.S., Chowdhury J.R. Hepatic gene transfer of the catalytic subunit of the apolipoprotein B mRNA editing enzyme results in a reduction of plasma LDL levels in normal and Watanabe heritable hyperlipidemic rabbits. J. Lipid Res. 37:1996;2001-2017.
16. Kozarsky K.F., Bonen D.K., Giannoni F., Funahashi T., Wilson J.M., Davidson N.O. Hepatic expression of the catalytic subunit of the apolipoprotein B mRNA editing (apobec-1) ameliorates hypercholesterolemia in LDL-receptor deficient rabbits. Hum. Gene Ther. 7:1996;943-957.
17. Hardtmann D.A., Pullinger C.R., Hamilton R.L., Kane J.P., Malloy M.J. Molecular and metabolic basis for the metabolic disorder normotriglyceridemic abetalipoproteinemia. J. Clin. Invest. 88:1991;1722-1729.
18. Powell-Braxton L., Veniant M., Latvala R.D., Hirano K.J., Won W.B., Ross J., Dybal N., Zlot C.H., Young S.G., Davidson N.O. A mouse model of human familial hypercholesterolemia: markedly elevated low density lipoprotein cholesterol levels and severe atherosclerosis on a low-fat chow diet. Nat. Med. 4:1998;934-938.
19. Yamanaka S., Balestra M.E., Ferrel L.D., Fan J., Arnold K.S., Taylor S., Taylor J.M., Innerarity T.L. Apolipoprotein B mRNA editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals. Proc. Natl. Acad. Sci. U. S. A. 92:1995;8483-8487.
20. Yamanaka S., Poksay K.S., Arnold K.S., Innerarity T.L. A novel translational repressor mRNA is edited in livers containing tumors caused by the transgene expression of the apo B mRNA editing enzyme. Genes Dev. 11:1997;321-333.
21. Qian X., Balestra M.E., Yamanaka S., Boren J., Lee I., Innerarity T.L. Low expression of the apolipoprotein B editing transgene in mice reduces LDL levels, but does not cause liver dysplasia or tumors. Arterioscler. Thromb. Vasc. Biol. 18:1998;1013-1020.
22. Greeve J., Lellek H., Apostel F., Hundoegger K., Barialai A., Kirsten R., Welker S., Greten H. Absence of APOBEC-1 mediated mRNA editing in human carcinomas. Oncogene. 18:1999;6357-6366.
23. Lichter P., Cremer T., Borden J., Manuelidis L., Ward D.C. Delineation of individual human chromosomes in metaphase and interphase cells by in situ suppression hybridization using recombinant DNA libraries. Hum. Genet. 80:1998;224-234.
24. Damman R., Li C., Yoon J.H., Chin P.L., Bates S., Pfeiffer G.P. Epigenetic inactivation of a RAS association domain family protein from the lung tumor suppressor locus 3p21.3. Nat. Genet. 25:2000;315-319.
25. Davidson N.O., Powell L.M., Wallis S.C., Scott J. Thyroid hormone modulates the introduction of a stop codon in rat liver apolipoprotein B mRNA. J. Biol. Chem. 263:1988;13482-13485.
26. Lorentz A., Plonne D., Schulze H.-P., Dargel R. Dexamethasone enhanced by insulin, but not by thyroid hormones stimulates apolipoprotein B mRNA editing in cultured rat hepatocytes depending on the developmental stage. FEBS Lett. 391:1996;57-60.
27. Shinar D., Yoffe O., Shani M., Yaffe D. Regulated expression of muscle-specific genes introduced into mouse embryonal stem cells: inverse correlation with DNA methylation. Differentiation. 41:1989;116-126.
28. Yoder J.A., Walsh C.P., Bestor T.H. Cytosine methylation and the ecology of intragenomic parasites. Trends Genet. 13:1997;335-340.
29. Razin A. CpG methylation, chromatin structure and gene silencing - a three way connection. EMBO J. 17:1998;4905-4908.
30. Campanaro M.R., Armstrong M.A., Flemington E.K. CpG methylation as a mechanism for the regulation of E2F activity. Proc. Natl. Acad. Sci. U. S. A. 97:2000;6481-6486.
31. Harrington M.A., Jones P.A., Imagawa M., Karin M. Cytosine methylation does not affect binding of the transcription factor Sp1. Proc. Natl. Acad. Sci. U. S. A. 85:1988;2066-2070.
32. Wade P.A., Gegonne A., Jones P.L., Bellestar E., Aubry F., Wolffe A.P. Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation. Nat. Genet. 23:1999;62-66.